World Health Organization Issues Warning Over Critical Lack of Obesity Jabs
Less than one in 10 patients eligible to benefit from weight-loss injections including Wegovy are able to get them, caution the WHO as it publishes its inaugural recommendations on the drugs.
Given in excess of 1,000,000,000 people worldwide currently obese, it is calling for more widespread and fairer availability to these injectable treatments.
According to projections, more than two billion could be living with obesity by 2030 unless action is taken.
"The latest guidance recognises that obesity is a chronic disease that can be treated with holistic and continuous care," said the agency's head Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and supply-chain constraints are major hurdles to widespread availability to the jabs that can help people shift substantial body mass, explains the organization.
GLP-1 Therapy Shortage
Even in the present most optimistic case, the supply of such drugs could only cover about 100 million people – less than 10% of those who need them, per the health organization.
The guideline calls on countries and companies to widen access, through strategies including patent sharing.
A patent on a key compound – the core ingredient of a leading brand – is scheduled to end in a number of countries in 2026.
The Way Weight-Loss Jabs Work
The injections replicate a biological compound to reduce digestion speed, reduce hunger and boost feelings of fullness so people reduce food intake.
People commonly begin shedding pounds in the initial weeks of beginning the weekly injections.
Studies indicates patients may regain a significant portion after a year of discontinuing the treatment, because their usual hunger come back.
To be overweight or obese increases your likelihood for experiencing medical conditions, including type 2 diabetes, heart disease, brain attack, and specific cancers.
Excess weight impacts individuals in every country and was associated with 3.7 million fatalities worldwide in 2024, according to the health agency.
